Paladin Partners’s Eli Lilly LLY Stock Holding History

Paladin Partners’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$369K	Hold	308	–	–	0.24%	35
2026 Q1	$283K	Hold	308	–	–	0.2%	36
2025 Q4	$331K	Buy	+308	New	+$295K	0.25%	34

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Paladin Partners's LLY Position: Q2 2026 in Review

Paladin Partners held its Eli Lilly (LLY) position steady in Q2 2026 at 308 shares worth $369K. The position accounts for 0.24% of the portfolio, ranked #35.

Paladin Partners first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. 4,599 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

Paladin Partners held 308 shares of Eli Lilly worth $369K as of Q2 2026.
Paladin Partners left its Eli Lilly share count unchanged in Q2 2026.
Eli Lilly made up 0.24% of Paladin Partners's portfolio in Q2 2026, its #35 holding.
Paladin Partners first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
4,599 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Paladin Partners's 13F filing for Q2 2026, filed 7 Aug 2026.